Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Grants
  • About Akademiliv

Mutation in lung cancer patients linked to increased risk of brain metastases

26 September, 2023

NEW STUDY. A population-based study of 6,000 lung cancer patients shows that patients with the KRAS G12C mutation have a high risk of brain metastases. Surprisingly this is not linked to worse survival. The study was conducted by researchers affiliated with Genomic Medicine Sweden and the National Swedish Lung Cancer Registry with support from Amgen.

Each year, approximately 4,000 patients are diagnosed with lung cancer in Sweden. In the most common form, non-small cell lung cancer (NSCLC), the tumor development is propelled by changes in genes that control cell proliferation, so called “driver genes”. The most commonly affected gene is KRAS, where several different gene mutations, for unknown reason, result in a very heterogeneous group of tumors. One of these KRAS mutations, the G12C variant, has been in focus in recent years because it can be targeted by specific drugs.

The study includes more than 6,000 patients in the Swedish National Lung Cancer Registry where a gene sequencing analysis was performed at diagnosis. The results show that the KRAS G12C mutation is strongly linked to smoking, more common in female patients and affects the spread of the cancer in a unique way compared to other KRAS mutations.

Johan Botling, Professor at the Department of Laboratory Medicine, Institute of Biomedicine. Photo: Johan Wingborg.

“The most interesting finding is that lung cancer patients with the G12C mutation in KRAS are more likely to get brain metastases than patients with other mutations,” says Johan Botling, Senior consultant at Sahlgrenska University Hospital and professor of pathology at Gothenburg University, who led the study.

The prognosis is the same

However, the survival analysis showed that patients with the KRAS G12C mutation who presented with brain metastases at diagnosis did not have a worse outcome compared to patients with other patterns of metastatic tumor dissemination.

“This finding surprised us. We noted that these lung cancer patients seem to get brain metastases earlier in their disease than others, but at the same time have fewer metastases in other organs. This might explain why these patients do better then expected,” says Johan Botling. In further studies, we will investigate how different KRAS mutations affect the response to treatment with chemotherapy, immunotherapy and targeted drugs.

An essential precondition of the study is that results from mutation diagnostics with NGS (next-generation sequencing) have been reported at a national level for lung cancer patients to the National Lung Cancer Registry since 2015.

High quality data

“The National Lung Cancer Registry is a unique resource for research where we, in order to evaluate existing treatments and develop new therapeutic procedures, can link molecular data with other patient information such as age, gender and treatment outcome. This is the first study where we have linked mutation data from the tumors with patient data in the registry,” says Gunnar Wagenius, Associate Professor and Senior consultant oncologist at Karolinska University Hospital and registry holder of the National Lung Cancer Registry.

“Thanks to early adoption of diagnostic biomarker testing in Sweden, we have the opportunity to generate high-quality real-world-data on large patient populations. This is of utmost importance for the design of new clinical trials in the area of targeted treatment. For us at Amgen, working with GMS and the lung cancer registry has been a rewarding collaboration that has resulted in important knowledge with global impact beyond Sweden.” says Sandra Eketorp Sylvan, Medical Director of Amgen Sweden.

“In this project we looked at mutations in one gene and obtained interesting results. With even broader gene sequencing developed within the GMS network, it will possible to explore the impact of hundreds of genes on large national patient populations. This knowledge will help us to better understand different types of lung cancer and how to improve treatment for individual patients.” concludes Johan Botling.

 

Publication

KRAS G12C Mutant Non–Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data from the National Swedish Lung Cancer Registry
Isaksson J, Berglund A, Louie K, Willén L, Hamidian A, Edsjö A, Enlund F, Planck M, Vikström A, Johansson M, Hallqvist A, Wagenius G, Botling J.
Clin Lung Cancer. 2023 Sep;24(6):507-518. doi: 10.1016/j.cllc.2023.05.002.

 

Facts

  • Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.
  • NSCLC affects approximately 3,500 patients annually in Sweden.
  • Currently, eight genes are tested to guide targeted therapies in lung cancer (EGFR, KRAS, BRAF, ALK, ROS1, RET, NTRK and METex14).
  • KRAS is the most common of these ‘driver’ mutations (present in about 30% of tumors).
  • Lung cancer with KRAS mutations is a very heterogeneous group of tumors.

 

BY: GENOMIC MEDICINE SWEDEN

By: Elin Lindström

HAPPY SUMMER!

The newsletter from Akademiliv will return on Wednesday, August 21st.

Contact your institute to add your event to the calendar in the Staff Portal

  • Biomedicine: Kristian Kvint: kalender@biomedicine.gu.se
  • Core Facilities: Amelie Karlsson: amelie.karlsson.2@gu.se
  • Clinical Sciences: Katarina Olinder Eriksson: klinvet@gu.se
  • Medicine: Nina Raun; kommunikation@medicine.gu.se
  • Neuroscience and Physiology: Josefin Bergenholtz; kommunikation@neuro.gu.se
  • Odontology: Johan Thompson; info@odontologi.gu.se
  • Sahlgrenska Academy’s Office and faculty-wide calendar events Åsa Ekvall; info@sahlgrenska.gu.se
  • Health and Care Sciences: Karin Mossberg; vardvetenskap@fhs.gu.se

Information from Sahlgrenska Academy Research Support Office

[UPDATED JUNE 2024]
The Sahlgrenska Academy Research Support Office provides an overview of upcoming and current calls, nominations and events in an information letter. This letter is updated on a monthly basis.
Current and previous newsletters are also available in the Staff Portal.

’20 minutes for researchers’ is back – see full spring program

During 20 minutes over Zoom, the Biomedical Library gives tips on tools and services that can facilitate your research everyday life.

More news

En personlig död (A Personal Death) – a chance to win Björn Fagerberg’s new book

27 May, 2024

NEW BOOK. During his career as a physician specializing in internal medicine, Björn Fagerberg has been involved in many end-of-life situations, …  

She is doing her residency in the US with a medical degree from Gothenburg

21 May, 2024

STUDENT. Doing a “residency” in orthopedics in the United States is an unattainable dream for many newly qualified American doctors. Now Janina Ka …  

Alba Corell reports from a high-level brain tumor meeting

20 May, 2024

COLUMN. The recent gathering of the Scandinavian Society of Neuro-oncology (SNOG) in Gothenburg has concluded. Professor Asgeir Jakola hosted and …  

From South Africa to Sweden: Collaborative Research Efforts Improving Pregnant Women’s Health

17 May, 2024

GLOBAL HEALTH. In the bustling Tygerberg University Hospital in Cape Town, a dedicated research team led by Lina Bergman, is on a mission to …  

Sara Bjursten and Anna Wenger are the recipients of the Assar Gabrielsson Prize 2024

17 May, 2024

AWARD. The Assar Gabrielsson Foundation has named Anna Wenger as the winner in the basic science research category and Sara Bjursten as the …  

A full day for PhD students focused on mental health

16 May, 2024

PHD STUDENTS. For the sixth time, PhD students at Sahlgrenska Academy were invited to PhD Day, organized by the Doctoral Student Council. The day …  

Kaj Blennow ranked highest in Sweden in neuroscience

16 May, 2024

AWARD. In this year's edition of the researcher ranking from Research.com in the field of neuroscience, Kaj Blennow is ranked 17th …  

Linda Wass is doing a postdoc at Stanford with ALF funding

14 May, 2024

ALF FUNDING. Biomedical Scientist Linda Wass has just settled in Stanford, California, where she will spend two years as a postdoc. She is the …  

Karin Nilsson wrote the Thesis of the Year at Sahlgrenska Academy in 2023

14 May, 2024

AWARD. Karin Nilsson, currently a postdoc at the Department of Internal Medicine and Clinical Nutrition, receives the faculty-wide Thesis of the …  

Some answers from the proposed members of the next Faculty Board

14 May, 2024

FACULTY ELECTIONS. The eight proposed members of the next Faculty Board hereby give some brief answers on how they want to contribute to the work …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen